Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Giant Cell Arteritis Therapeutic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Prednisone Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Giant Cell Arteritis Therapeutic include Sanofi, Kiniksa Pharmaceuticals, Ltd., Regeneron, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Novartis AG, AbbVie, Inc., Bristol-Myers Squibb Company and Abbott, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Giant cell arteritis (GCA) is a granulomatous medium and large-vessel vasculitis. It is the most common form of systemic vasculitis, with an incidence of between 15 and 25 cases per 100,000 persons over 50 years of age.
This report aims to provide a comprehensive presentation of the global market for Giant Cell Arteritis Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Giant Cell Arteritis Therapeutic. This report contains market size and forecasts of Giant Cell Arteritis Therapeutic in global, including the following market information:
Global Giant Cell Arteritis Therapeutic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Giant Cell Arteritis Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Giant Cell Arteritis Therapeutic Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Giant Cell Arteritis Therapeutic Market Segment Percentages, by Type, 2022 (%)
Prednisone
Methotrexate
Tocilizumab
Aspirin
Global Giant Cell Arteritis Therapeutic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Giant Cell Arteritis Therapeutic Market Segment Percentages, by Application, 2022 (%)
Corticosteroids
Immunosuppressive Agents
Anticoagulants
Others
Global Giant Cell Arteritis Therapeutic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Giant Cell Arteritis Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Giant Cell Arteritis Therapeutic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Giant Cell Arteritis Therapeutic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Kiniksa Pharmaceuticals, Ltd.
Regeneron
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd.
Novartis AG
AbbVie, Inc.
Bristol-Myers Squibb Company
Abbott
Johnson & Johnson Services, Inc.
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Giant Cell Arteritis Therapeutic, market overview.
Chapter 2: Global Giant Cell Arteritis Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Giant Cell Arteritis Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Giant Cell Arteritis Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Giant Cell Arteritis Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Giant Cell Arteritis Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Giant Cell Arteritis Therapeutic Overall Market Size
2.1 Global Giant Cell Arteritis Therapeutic Market Size: 2022 VS 2029
2.2 Global Giant Cell Arteritis Therapeutic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Giant Cell Arteritis Therapeutic Players in Global Market
3.2 Top Global Giant Cell Arteritis Therapeutic Companies Ranked by Revenue
3.3 Global Giant Cell Arteritis Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Giant Cell Arteritis Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Giant Cell Arteritis Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Giant Cell Arteritis Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Giant Cell Arteritis Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Giant Cell Arteritis Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Giant Cell Arteritis Therapeutic Market Size Markets, 2022 & 2029
4.1.2 Prednisone
4.1.3 Methotrexate
4.1.4 Tocilizumab
4.1.5 Aspirin
4.2 By Type - Global Giant Cell Arteritis Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Giant Cell Arteritis Therapeutic Revenue, 2018-2023
4.2.2 By Type - Global Giant Cell Arteritis Therapeutic Revenue, 2024-2029
4.2.3 By Type - Global Giant Cell Arteritis Therapeutic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Giant Cell Arteritis Therapeutic Market Size, 2022 & 2029
5.1.2 Corticosteroids
5.1.3 Immunosuppressive Agents
5.1.4 Anticoagulants
5.1.5 Others
5.2 By Application - Global Giant Cell Arteritis Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Giant Cell Arteritis Therapeutic Revenue, 2018-2023
5.2.2 By Application - Global Giant Cell Arteritis Therapeutic Revenue, 2024-2029
5.2.3 By Application - Global Giant Cell Arteritis Therapeutic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Giant Cell Arteritis Therapeutic Market Size, 2022 & 2029
6.2 By Region - Global Giant Cell Arteritis Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Giant Cell Arteritis Therapeutic Revenue, 2018-2023
6.2.2 By Region - Global Giant Cell Arteritis Therapeutic Revenue, 2024-2029
6.2.3 By Region - Global Giant Cell Arteritis Therapeutic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Giant Cell Arteritis Therapeutic Revenue, 2018-2029
6.3.2 US Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.3.3 Canada Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.3.4 Mexico Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Giant Cell Arteritis Therapeutic Revenue, 2018-2029
6.4.2 Germany Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.4.3 France Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.4.4 U.K. Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.4.5 Italy Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.4.6 Russia Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.4.7 Nordic Countries Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.4.8 Benelux Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Giant Cell Arteritis Therapeutic Revenue, 2018-2029
6.5.2 China Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.5.3 Japan Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.5.4 South Korea Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.5.5 Southeast Asia Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.5.6 India Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Giant Cell Arteritis Therapeutic Revenue, 2018-2029
6.6.2 Brazil Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.6.3 Argentina Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Giant Cell Arteritis Therapeutic Revenue, 2018-2029
6.7.2 Turkey Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.7.3 Israel Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.7.4 Saudi Arabia Giant Cell Arteritis Therapeutic Market Size, 2018-2029
6.7.5 UAE Giant Cell Arteritis Therapeutic Market Size, 2018-2029
7 Giant Cell Arteritis Therapeutic Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Giant Cell Arteritis Therapeutic Major Product Offerings
7.1.4 Sanofi Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Kiniksa Pharmaceuticals, Ltd.
7.2.1 Kiniksa Pharmaceuticals, Ltd. Company Summary
7.2.2 Kiniksa Pharmaceuticals, Ltd. Business Overview
7.2.3 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Major Product Offerings
7.2.4 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.2.5 Kiniksa Pharmaceuticals, Ltd. Key News & Latest Developments
7.3 Regeneron
7.3.1 Regeneron Company Summary
7.3.2 Regeneron Business Overview
7.3.3 Regeneron Giant Cell Arteritis Therapeutic Major Product Offerings
7.3.4 Regeneron Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.3.5 Regeneron Key News & Latest Developments
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Company Summary
7.4.2 GlaxoSmithKline plc Business Overview
7.4.3 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Major Product Offerings
7.4.4 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline plc Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 Novartis AG
7.6.1 Novartis AG Company Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Giant Cell Arteritis Therapeutic Major Product Offerings
7.6.4 Novartis AG Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.6.5 Novartis AG Key News & Latest Developments
7.7 AbbVie, Inc.
7.7.1 AbbVie, Inc. Company Summary
7.7.2 AbbVie, Inc. Business Overview
7.7.3 AbbVie, Inc. Giant Cell Arteritis Therapeutic Major Product Offerings
7.7.4 AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.7.5 AbbVie, Inc. Key News & Latest Developments
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Company Summary
7.8.2 Bristol-Myers Squibb Company Business Overview
7.8.3 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Major Product Offerings
7.8.4 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.8.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Giant Cell Arteritis Therapeutic Major Product Offerings
7.9.4 Abbott Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.9.5 Abbott Key News & Latest Developments
7.10 Johnson & Johnson Services, Inc.
7.10.1 Johnson & Johnson Services, Inc. Company Summary
7.10.2 Johnson & Johnson Services, Inc. Business Overview
7.10.3 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Major Product Offerings
7.10.4 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.10.5 Johnson & Johnson Services, Inc. Key News & Latest Developments
7.11 Johns Hopkins Hospital
7.11.1 Johns Hopkins Hospital Company Summary
7.11.2 Johns Hopkins Hospital Business Overview
7.11.3 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Major Product Offerings
7.11.4 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.11.5 Johns Hopkins Hospital Key News & Latest Developments
7.12 Fortis Healthcare
7.12.1 Fortis Healthcare Company Summary
7.12.2 Fortis Healthcare Business Overview
7.12.3 Fortis Healthcare Giant Cell Arteritis Therapeutic Major Product Offerings
7.12.4 Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.12.5 Fortis Healthcare Key News & Latest Developments
7.13 American College of Rheumatology
7.13.1 American College of Rheumatology Company Summary
7.13.2 American College of Rheumatology Business Overview
7.13.3 American College of Rheumatology Giant Cell Arteritis Therapeutic Major Product Offerings
7.13.4 American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.13.5 American College of Rheumatology Key News & Latest Developments
7.14 Duke University Health System
7.14.1 Duke University Health System Company Summary
7.14.2 Duke University Health System Business Overview
7.14.3 Duke University Health System Giant Cell Arteritis Therapeutic Major Product Offerings
7.14.4 Duke University Health System Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.14.5 Duke University Health System Key News & Latest Developments
7.15 Lahey Clinic Foundation
7.15.1 Lahey Clinic Foundation Company Summary
7.15.2 Lahey Clinic Foundation Business Overview
7.15.3 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Major Product Offerings
7.15.4 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue in Global Market (2018-2023)
7.15.5 Lahey Clinic Foundation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
